| 41.90 Delayed Data As of May 17 |  +0.24 / +0.58%Today’s Change | 37.67 Today|||52-Week Range 45.62 | -3.48% Year-to-Date |
| These 6 Giants Control Half the Global Video Game Market May 17 / MotleyFool.comFOO - Paid Partner Content | Here's the Bad News That Derailed Regeneron's Stock May 08 / MotleyFool.com - Paid Partner Content |
| Pfizer's Eczema Candidate Meets All Goals in Phase III Study May 16 / Zacks.comZAK - Paid Partner Content | Regeneron (REGN) Stock Down on Earnings, Sales Miss in Q1 May 07 / Zacks.com - Paid Partner Content |
| Insulet and West Pharma Proven Winners in Growing Wearable Devices Market May 15 / GuruFocus News - Paid Partner Content | The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo May 06 / Zacks.com - Paid Partner Content |
| Inovio (INO) Q1 Earnings & Revenues Fall Short of Estimates May 10 / Zacks.com - Paid Partner Content |
| Previous close | 41.66 |
| Today’s open | 41.69 |
| Day’s range | 41.68 - 42.05 |
| Volume | 1,407,231 |
| Average volume (3 months) | 1,020,762 |
| Market cap | $104.6B |
| Earnings growth (last year) | +19.94% |
| Earnings growth (this year) | +3.61% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +2.83% |
| P/E ratio | 21.8 |
| Price/Sales | 2.68 |
| Price/Book | 1.55 |
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.12 | +0.31% |
| LLYEli Lilly and Co | -0.72 | -0.62% |
| AZNAstraZeneca | -0.02 | -0.05% |
| ABBVAbbVie | -0.04 | -0.05% |
| Next reporting date | July 29, 2019 |
| EPS forecast (this quarter) | $0.69 |
| Annual revenue (last year) | $40.7B |
| Annual profit (last year) | $5.1B |
| Net profit margin | 12.53% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Director Olivier Brandicourt |
Chief Financial Officer & Executive Vice President Jean-Baptiste Chasseloup de Chatillon |
Corporate headquarters Paris, Ile-de-france |
